Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity.

Ong FS, Lin CX, Campbell DJ, Okwan-Duodu D, Chen X, Blackwell WL, Shah KH, Gonzalez-Villalobos RA, Shen XZ, Fuchs S, Bernstein KE.

Hypertension. 2012 Feb;59(2):283-90. doi: 10.1161/HYPERTENSIONAHA.111.180844. Epub 2011 Dec 27.

2.

Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice.

Alghamri MS, Weir NM, Anstadt MP, Elased KM, Gurley SB, Morris M.

J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):138-51. doi: 10.1177/1074248412460124. Epub 2012 Oct 5.

PMID:
23043153
3.

Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.

Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, Sparks MA, Jin H, Wu M, Lin EE, Crowley SD.

Hypertension. 2014 Dec;64(6):1275-81. doi: 10.1161/HYPERTENSIONAHA.114.03863. Epub 2014 Sep 2.

4.

Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.

Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG.

Am J Physiol Renal Physiol. 2010 Jan;298(1):F150-7. doi: 10.1152/ajprenal.00477.2009. Epub 2009 Oct 21.

5.

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.

Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M.

Cardiovasc Res. 2014 Feb 1;101(2):236-46. doi: 10.1093/cvr/cvt245. Epub 2013 Nov 4.

PMID:
24193738
6.

Sex-specific T-cell regulation of angiotensin II-dependent hypertension.

Ji H, Zheng W, Li X, Liu J, Wu X, Zhang MA, Umans JG, Hay M, Speth RC, Dunn SE, Sandberg K.

Hypertension. 2014 Sep;64(3):573-82. doi: 10.1161/HYPERTENSIONAHA.114.03663. Epub 2014 Jun 16.

7.

Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo.

Fuchs S, Xiao HD, Hubert C, Michaud A, Campbell DJ, Adams JW, Capecchi MR, Corvol P, Bernstein KE.

Hypertension. 2008 Feb;51(2):267-74. Epub 2007 Dec 24.

8.

Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.

Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE.

Hypertension. 2004 Apr;43(4):854-9. Epub 2004 Feb 9.

9.

Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.

Gonzalez-Villalobos RA, Satou R, Seth DM, Semprun-Prieto LC, Katsurada A, Kobori H, Navar LG.

Hypertension. 2009 Feb;53(2):351-5. doi: 10.1161/HYPERTENSIONAHA.108.124511. Epub 2008 Dec 15.

10.

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C.

Circ Res. 2010 Oct 1;107(7):888-97. doi: 10.1161/CIRCRESAHA.110.219279. Epub 2010 Jul 29.

11.

Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.

Fuchs S, Xiao HD, Cole JM, Adams JW, Frenzel K, Michaud A, Zhao H, Keshelava G, Capecchi MR, Corvol P, Bernstein KE.

J Biol Chem. 2004 Apr 16;279(16):15946-53. Epub 2004 Feb 2.

12.

Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.

Kamat NV, Thabet SR, Xiao L, Saleh MA, Kirabo A, Madhur MS, Delpire E, Harrison DG, McDonough AA.

Hypertension. 2015 Mar;65(3):569-76. doi: 10.1161/HYPERTENSIONAHA.114.04975. Epub 2015 Jan 19.

13.

ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Sriramula S, Cardinale JP, Lazartigues E, Francis J.

Cardiovasc Res. 2011 Dec 1;92(3):401-8. doi: 10.1093/cvr/cvr242. Epub 2011 Sep 27.

14.

Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.

Tikellis C, Pickering R, Tsorotes D, Du XJ, Kiriazis H, Nguyen-Huu TP, Head GA, Cooper ME, Thomas MC.

Clin Sci (Lond). 2012 Oct;123(8):519-29. doi: 10.1042/CS20110668.

PMID:
22616805
15.

Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury.

Li P, Xiao HD, Xu J, Ong FS, Kwon M, Roman J, Gal A, Bernstein KE, Fuchs S.

Am J Pathol. 2010 Sep;177(3):1113-21. doi: 10.2353/ajpath.2010.081127. Epub 2010 Jul 22.

16.

Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure.

Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE.

Circ Res. 2002 Jan 11;90(1):87-92.

17.

Angiotensin-converting enzyme is required for normal myelopoiesis.

Lin C, Datta V, Okwan-Duodu D, Chen X, Fuchs S, Alsabeh R, Billet S, Bernstein KE, Shen XZ.

FASEB J. 2011 Apr;25(4):1145-55. doi: 10.1096/fj.10-169433. Epub 2010 Dec 9.

18.

High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.

Zhao X, White R, Huang BS, Van Huysse J, Leenen FH.

J Hypertens. 2001 Jan;19(1):89-98.

PMID:
11204309
19.

Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism.

Jiménez-Ferrer E, Badillo FH, González-Cortazar M, Tortoriello J, Herrera-Ruiz M.

J Ethnopharmacol. 2010 Jul 20;130(2):340-6. doi: 10.1016/j.jep.2010.05.013. Epub 2010 May 19.

PMID:
20488233
20.

Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.

Perry GJ, Mori T, Wei CC, Xu XY, Chen YF, Oparil S, Lucchesi P, Dell'Italia LJ.

Circulation. 2001 Feb 20;103(7):1012-6.

Supplemental Content

Support Center